ClinicalTrials.govpublic full text
To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects
solid tumours, phase i, healthy, pharmacokinetics, renal impairment, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804506
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.